Home

Helix Holdings II reported a 31.59% stake in BridgeBio Oncology Therapeutics BBOT · 7,389,000 sh · amendment

Trade details

Type
5% stake report
Report
13D · amendment
Stake
31.59%
Last report
No earlier report
Shares held
7,389,000 sh
Class
Class A ordinary shares, $0.0001 par value per share
Event date
25/02/28
Filed
25/03/04

31.59% stake

BridgeBio Oncology Therapeutics trades, last 26 weeks

What else happened in BridgeBio Oncology Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/29~25/03/30

Helix Holdings II's other 5% stake reports

  • Helix Holdings II

    5% stakeBridgeBio Oncology Therapeutics

    22.6% stake

    Filed 25/08/13